We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+30.09%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.08B
AUM Growth
+$206M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 57.34%
2 Consumer Staples 25.84%
3 Industrials 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.21B
$521M 48.4%
10,855,179
MNST icon
2
Monster Beverage
MNST
$94.3B
$278M 25.84%
9,547,416
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$70.8M 6.58%
420,000
LCTX icon
4
Lineage Cell Therapeutics
LCTX
$269M
$70.4M 6.54%
34,257,494
AXON
5
Axon Enterprise
AXON
$42.5B
$52M 4.83%
760,062
MNST icon
6
PUT
Monster Beverage
MNST
$94.3B
$46.6M 4.33%
1,600,000
IMDX
7
Insight Molecular Diagnostics
IMDX
$150M
$18.9M 1.76%
378,247
DAL icon
8
PUT
Delta Air Lines
DAL
$57.5B
$11.6M 1.07%
200,000
AST
9
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$6.88M 0.64%
5,292,156

Similar funds

Broadwood Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Broadwood Capital held 9 positions worth $1.08B, up 24% from $871M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 49% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital's ten largest holdings make up 100% of its $1.08B portfolio in Q3 2018.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2018.
  • Broadwood Capital's portfolio value rose 24% quarter-over-quarter to $1.08B.

Based on Broadwood Capital's 13F filing for Q3 2018, filed 14 Nov 2018.